NEW! MyMRD Gene Panel – Now CLIA Validated

2019-04-29T19:22:31+00:00November 2nd, 2016|Categories: Product Releases|

The MyMRD is a hotspot panel that detects all classes of variants identified in a precisely defined set of targets that commonly drive myeloid malignancies including AML, MPN and MDS. It can detect SNV, indels and translocations to the genomic basepair, giving unparalleled precision and detection of low level mutations in patients.